Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
China lung cancer screening (CLUS) version 2.0 with new techniques implemented: Artificial intelligence, circulating molecular biomarkers and autofluorescence bronchoscopy.
Zhang Y, Qian F, Teng J, Wang H, Yu H, Chen Q, Wang L, Zhu J, Yu Y, Yuan J, Cai W, Xu N, Zhu H, Lu Y, Yao M, Zhu J, Dong J, Yu L, Ren H, Yang J, Sun J, Zhong H, Han B. Zhang Y, et al. Among authors: zhong h. Lung Cancer. 2023 Jul;181:107262. doi: 10.1016/j.lungcan.2023.107262. Epub 2023 May 27. Lung Cancer. 2023. PMID: 37263180
Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial.
Han B, Jin B, Chu T, Niu Y, Dong Y, Xu J, Gu A, Zhong H, Wang H, Zhang X, Shi C, Zhang Y, Zhang W, Lou Y, Zhu L, Pei J. Han B, et al. Among authors: zhong h. Int J Cancer. 2017 Sep 15;141(6):1249-1256. doi: 10.1002/ijc.30806. Epub 2017 Jun 21. Int J Cancer. 2017. PMID: 28560853 Free article. Clinical Trial.
Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Prospective, Single-Arm, Phase II Study.
Xiong L, Li R, Sun J, Lou Y, Zhang W, Bai H, Wang H, Shen J, Jing B, Shi C, Zhong H, Gu A, Jiang L, Shi J, Fang W, Zhao H, Zhang J, Wang J, Ye J, Han B. Xiong L, et al. Among authors: zhong h. Oncologist. 2019 Feb;24(2):157-e64. doi: 10.1634/theoncologist.2018-0120. Epub 2018 Aug 29. Oncologist. 2019. PMID: 30158288 Free PMC article. Clinical Trial.
5,395 results